Avidity Biosciences, Inc.
RNA
$49.77
-$1.00-1.97%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -8.92% | 50.66% | 152.20% | 192.78% | 125.33% |
| Total Receivables | -45.65% | 304.67% | 227.29% | 1,821.00% | 1,228.32% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 13.78% | 93.66% | 71.43% | 18.14% | 27.76% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -5.89% | 53.56% | 152.29% | 191.97% | 123.50% |
|
|
|||||
| Total Current Assets | -5.89% | 53.56% | 152.29% | 191.97% | 123.50% |
| Net Property, Plant & Equipment | 60.12% | 26.33% | 9.83% | -7.31% | -0.42% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2,863.09% | 390.83% | 456.38% | 387.17% | 339.36% |
| Total Assets | 1.60% | 53.35% | 148.81% | 186.27% | 120.61% |
|
|
|||||
| Total Accounts Payable | -55.97% | 182.38% | -3.95% | 38.05% | 57.24% |
| Total Accrued Expenses | 153.42% | 41.13% | 62.35% | 60.14% | 37.48% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.25% | 4.24% | 5.63% | 5.61% | 19.49% |
| Total Finance Division Other Current Liabilities | -49.29% | -46.45% | -26.01% | 898.98% | 600.71% |
| Total Other Current Liabilities | -49.29% | -46.45% | -26.01% | 898.98% | 600.71% |
| Total Current Liabilities | 60.38% | 13.22% | 21.49% | 87.48% | 86.13% |
|
|
|||||
| Total Current Liabilities | 60.38% | 13.22% | 21.49% | 87.48% | 86.13% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -73.79% | -61.45% | -52.41% | -45.59% | -27.43% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.47% | 7.96% | -7.18% | -- | -- |
| Total Liabilities | 39.46% | 8.11% | 8.72% | 146.68% | 144.91% |
|
|
|||||
| Common Stock & APIC | 22.01% | 58.72% | 116.08% | 122.12% | 89.44% |
| Retained Earnings | -64.15% | -57.72% | -56.47% | -54.96% | -55.12% |
| Treasury Stock & Other | 492.27% | 696.12% | 2,221.60% | 478.17% | 83.01% |
| Total Common Equity | -2.32% | 59.91% | 184.56% | 190.53% | 118.36% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.32% | 59.91% | 184.56% | 190.53% | 118.36% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.32% | 59.91% | 184.56% | 190.53% | 118.36% |
|
|
|||||